GANGLIONEUROBLASTOMA, NODULAR
Clinical trials for GANGLIONEUROBLASTOMA, NODULAR explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA, NODULAR trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, NODULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to boost survival for kids with tough cancer
Disease control Recruiting nowThis study is testing if adding a drug called dinutuximab to the first stage of treatment helps children with newly diagnosed high-risk neuroblastoma. Dinutuximab is an immunotherapy that helps the body's own immune system find and kill cancer cells. The trial will compare the cu…
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Major trial tests new weapons against deadly childhood cancer
Disease control Recruiting nowThis large, late-stage study is testing if adding one of two new treatments to the current intensive therapy helps children with newly diagnosed, high-risk neuroblastoma. One approach uses a radioactive drug that targets the tumor. The other uses a daily pill (lorlatinib) for chi…
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC